Suppr超能文献

增强HEK293E细胞中重组抗体的生产:优化转染和培养参数。

Augmenting recombinant antibody production in HEK293E cells: optimizing transfection and culture parameters.

作者信息

Heng Zealyn Shi-Lin, Yeo Joshua Yi, Koh Darius Wen-Shuo, Gan Samuel Ken-En, Ling Wei-Li

机构信息

Antibody & Product Development Lab, EDDC-BII, Agency for Science, Technology and Research (ASTAR), Singapore 138672, Singapore.

APD SKEG Pte Ltd., Singapore 439444, Singapore.

出版信息

Antib Ther. 2022 Jan 10;5(1):30-41. doi: 10.1093/abt/tbac003. eCollection 2022 Jan.

Abstract

BACKGROUND

Optimizing recombinant antibody production is important for cost-effective therapeutics and diagnostics. With impact on commercialization, higher productivity beyond laboratory scales is highly sought, where efficient production can also accelerate antibody characterizations and investigations.

METHODS

Investigating HEK293E cells for mammalian antibody production, various transfection and culture parameters were systematically analyzed for antibody light chain production before evaluating them for whole antibody production. Transfection parameters investigated include seeding cell density, the concentration of the transfection reagent and DNA, complexation time, temperature, and volume, as well as culture parameters such as medium replacement, serum deprivation, use of cell maintenance antibiotic, incubation temperature, medium volume, post-transfection harvest day, and common nutrient supplements.

RESULTS

Using 2 mL adherent HEK293E cell culture transfections with 25 kDa linear polyethylenimine in the most optimized parameters, we demonstrated a ~2-fold production increase for light chain alone and for whole antibody production reaching 536 and 49 μg, respectively, in a cost-effective manner. With the addition of peptone, κ light chain increased by ~4-fold to 1032 μg, whereas whole antibody increased to a lesser extent by ~2.5-fold to 51 μg, with benefits potentially for antibodies limited by their light chains in production.

CONCLUSIONS

Our optimized findings show promise for a more efficient and convenient antibody production method through transfection and culture optimizations that can be incorporated to scale-up processes and with potential transferability to other mammalian-based recombinant protein production using HEK293E.

摘要

背景

优化重组抗体生产对于具有成本效益的治疗和诊断至关重要。由于对商业化有影响,人们迫切希望在实验室规模之外实现更高的生产力,高效生产还可以加速抗体的表征和研究。

方法

研究用于哺乳动物抗体生产的HEK293E细胞,在评估其全抗体生产之前,系统分析各种转染和培养参数对抗体轻链生产的影响。研究的转染参数包括接种细胞密度、转染试剂和DNA的浓度、复合时间、温度和体积,以及培养参数,如培养基更换、血清剥夺、细胞维持抗生素的使用、孵育温度、培养基体积、转染后收获天数和常见营养补充剂。

结果

在最优化的参数下,使用25 kDa线性聚乙烯亚胺对2 mL贴壁HEK293E细胞培养物进行转染,我们以具有成本效益的方式证明,单独轻链的产量提高了约2倍,全抗体产量分别达到536 μg和49 μg。添加蛋白胨后,κ轻链增加了约4倍,达到1032 μg,而全抗体增加幅度较小,约为2.5倍,达到51 μg,这对于生产中受轻链限制的抗体可能有益。

结论

我们的优化结果表明通过转染和培养优化有望实现更高效、便捷的抗体生产方法,可纳入放大过程,并有可能转移到使用HEK293E的其他基于哺乳动物的重组蛋白生产中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d55f/8825235/1cd5132e13e2/tbac003f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验